Technology Intensified Diabetes Education Study in African Americans
Part of paid clinical trials in Charleston, South Carolina.
- Sponsor
- State University of New York at Buffalo
- Study ID
- NCT02088658
- Status
- Completed
Conditions
- Diabetes Mellitus, Adult-Onset
- Diabetes Mellitus, Non-Insulin-Dependent
- Diabetes Mellitus, Noninsulin Dependent
- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Type II
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 100 Years
- Healthy Volunteers
- Not accepted
Interventions
- Technology Intensified — BEHAVIORALThe intervention is based on the Information-Motivation-Behavioral Skills (IMB) model and provides information, motivation, and behavioral skills training (using motivational enhancement techniques). Patients will be assigned the FORA 2-in-1 Telehealth System and provided glucose test strips to allow testing at least once a day. They will be asked to perform glucose testing and blood pressure measurement using the FORA system once daily. They will be asked to upload the measurements daily as soon as possible after the test is performed. The nurse educators will have access to a secure server to which the uploaded measurements are stored in real time. The glucose and BP readings will be used to tailor and reinforce behavior change during weekly telephone-delivered diabetes education sessions.
Study Details
The purpose of this study is to test the usefulness of an intervention that combines technology with diabetes education and skills training. This study has been designed specifically for African Americans with poorly controlled type 2 diabetes.
Key Dates
- Start date
- May 31, 2013
- Status verified
- Feb 2026
- Primary completion
- Dec 31, 2021
- Completion
- Jan 31, 2026
Study Design
- Enrollment
- 200 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Techonology IntensifiedSubjects randomized to this group will receive: 1) the FORA system for self-monitoring; 2) weekly telephone-delivered diabetes education/skills training; 3) patient activation (list of 5 questions to ask their provider at every visit and training on how to ask the questions); and 4) patient empowerment (diabetes responsibility contracts, personal goals, and flow charts for patients to record lab results/medications and training on how to use the empowerment tools). The intervention will be delivered by telephone once a week for 12 weeks with each session lasting \~30 minutes.
- No Intervention: Usual CareApart from study visits, patients will be followed by their primary care providers. The provider will be responsible for determining treatment parameters, making changes in the treatment regimen, and determining the timing of follow up visits. Between scheduled office encounters, contact between patient and provider will be patient initiated. The provider may use clinic nurses to follow up on problematic patients or patients with abnormal results. In essence, this group will receive the current standard of care at the study clinics.
Primary Outcome Measure
Hemoglobin A1c [ Time Frame: 12 months post randomization ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical University of South Carolina | Charleston | South Carolina | 29425 | - |
Find similar trials in Charleston, SC
By condition
By specialty
By research site
Related Studies
- Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner DyadsRecruiting · University of South Carolina · Columbia, South Carolina
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsRecruiting · Cleerly, Inc. · Chandler, Arizona
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseasePHASE3 · Recruiting · Boehringer Ingelheim · Anniston, Alabama
- A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal InsulinPHASE2 · Recruiting · Eli Lilly and Company · Tucson, Arizona